• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/3

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

3 Cards in this Set

  • Front
  • Back

Non cardiogenic pulmonary edema



Abrupt onset of hypoxemia and diffuse pul infiltrate


Absence of cardiac failure



ARDS is severe ALI



Both with inflammation associated increase in pul vascular permeability , epithelial and endothelial cells death



ARDS - acute diffuse inflammatory lung injury leading to increased pul vascular permeability, increased lung lung weight, loss of aerated lung tissue with hypoxemia and bilateral radiogenic opacities associated with increased venous admixture, increased physiological dead space and decreased lung compliance





Clinical presentation



Acute dyspnea


Hypoxemia


Bilateral pulmonary infiltrate on radiograph


No clinical evidence of primary left heart failure






Conditions associated with devt of ARDS



Infections -. Sepsis, gastric aspiration, diffuse pulmonary infections eg miliary TB



Physical injury - head injury, burns, fracture with fat embolism, near drowning


Inhaled irritants - oxygen toxicity, smoke, irritants gas



Chemical injury - heroine, methadone, acetylsalicylic acid, barbiturates



Others - DIC, multiple transfusion, uraemia, pancreatitis, hypersensitivity reaction
















Exudative phase



Inflammation damage


Endo and epithelial cells - increase permeability



Inhaled irritants - oxygen toxicity, smoke, irritants gas



Chemical injury - heroine, methadone, acetylsalicylic acid, barbiturates



Others - DIC, multiple transfusion, uraemia, pancreatitis, hypersensitivity reaction




Pathogenesis



Alveolar capillary membrane has two separate barriers - microvascular endothelium and alveolar epithelium



Integrity of this barriers compromised by endothelial or epithelium injury o both



Injury due to imbalance btwn proinflammatory and anti Inflammatory mediators



Exudative phase



Inflammation damage


Endo and epithelial cells - increase permeability



Exudate fill the alveoli



Alveolar epithelial cells injured, basement membrane denuded, surfactant production and fluid resorption inhibited



Hyaline membrane form( cellular debris, fibrin)



Endothelial damage triggers coagulation pathway, micro emboli form



DetailedInjury caus release of proinflammatory cytokines



Activated neutrophils secret TNF Alpha, interleukins to increase inflammatory reaction



Neutrophils produce reactive oxygen free radicals and protease that injure capillary endotheliumIncreased permeability, Influx of protein rich fluid in alveolar space



Exudate fill the alveoli



Alveolar epithelial cells injured, basement membrane denuded, surfactant production and fluid resorption inhibited



Hyaline membrane form( cellular debris, fibrin)



Endothelial damage triggers coagulation pathway, micro emboli form





Injury caus release of proinflammatory cytokines



Activated neutrophils secret TNF Alpha, interleukins to increase inflammatory reaction



Detailed



Injury caus release of proinflammatory cytokines



Activated neutrophils secret TNF Alpha, interleukins to increase inflammatory reaction



Neutrophils produce reactive oxygen free radicals and protease that injure capillary endothelium



Increased permeability,



Influx of protein rich fluid in alveolar space


Neutrophils produce reactive oxygen free radicals and protease that injure capillary endothelium



Increased permeability, Influx of protein rich fluid in alveolar space



Morphology



Acute - heavy,firm red boggy lungs



Exhibit congestion, interstitial and intraalveolar edema, Inflammation, fibrin deposit, diffuse alveolar damage



Alveolar walls lined with waxy hyaline membrane


Hyaline membrane ( fibrin, rich edema fluid mixed with cytoplasmic and lipid remnants of necrotic epithelial cells)



Organizing stage- type 2 pneumocytes proliferation, granulation tissue in alveolar walls and space



Granulation tissue resolves in most cases



Fibrotic thickening of alveolar septa , by proliferation of of interstitial cells and collagen deposit





Gross



Acute


Heavy, firm, dark red



Proliferation phase


Firm pale gray( fibroblast)



Fibrotic


Firm, gray white, cystic changes ie honey comb







Histopathological change



Diffuse alveolar damage ( marked desquamation of type I epithelial cells







Pathological stages



Exudative -. Diffuse alveolar damage in first week



Proliferative -. Resolution of pulmonary edema, poliferation of type 2 pneumocytes, squamous metaplasia, interstitial infiltration of myofibroblasts, early collagen deposit



Fibrotic- obliteration of normal lung architecture, diffuse fibrosis, cystic formation






Resolution



Removal of exudate, dear cells and replacement


By macrophages


Replacement by type 2 pneumocytes

Clinical features



Tachypnea, tachycardia in 12-24hrs


Ventilation perfusion mismatch due to alveolar flooding


Reduced lung compliance



Respiratory failure in 48 hrs of onset






Treatment



Patient die from multiple organs failure


Minimize condition like nosocomial infections, Gi bleeding, thromboembolism



Stress ulcers prophylaxis


Nutrition


Hyaline membrane disease



Disease of premature infants


60% of infants less than 28 week, 15-20% on 32-36 week, less than 5% for 37 week



Manifest within 48 hrs of birth


Deficiency of surfactant in alveoli


Leads to acute respiratory distress with fatal termination




Etiology - def of surfactant in the alveoli





Surfactant



Seen in fetal lung 16 week, proper at 24 week, abundant at 35 week


By type 2 pneumocytes


Lower surface tension decreasing pressure required to keep alveoli open



Alveolar collapse in lack of surfactant, greater inspiration effort needed







Risk factor



Premature


Multiple births


Maternal diabetes


CS without labour


Prenatal asphyxia


White race, male


Hypothermia

Pathophysiology



Prematurity ( immature lung with underdeveloped and un inflated alveoli)


Decreased surfactant


Increased alveolar surface tension


Atelectasis - CO2 retention; hypoxemia


Acidosis


Pul vasoconstriction and hypo profusion


Capillary damage


Plasma leak


Fibrinogen


Hyaline membrane









Morphology



Gross



Solid, red airless lungs resemble liver


Beefy lungs


Heavy and will sink in cup of water




Chest x-ray


No any black air spaces - only whitish areas


Ground glass picture







Clinical features



Appear in minutes after birth


Tachypnea greater than 60


Nasal flaring


Subcostal and intercostal retraction, cyanosis, expiratory grunting


Apnea


Irregular respiration


Diminished breath sounds, fine rales


Diagnosis



Antenatal



Examination of amniotic fluid ie lecithin sphingomyelin ratio



If greater than 2 full maturation


1.5-1.99 borderline maturation


Less - severe ARDS



Lab tests


Paco2 elevated


Partial pressure of oxygen low


Blood pH low due to metabolic acidosis


Calcium low


Serum glucose low







Management



Antenatal corticosteroids therapy


Beta methasone


Induce surfactant production


Surfactant replacement therapy